Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(R)-2-(2-[[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]methyl]pyrrolidin-1-yl)-2-oxoethanol | IC50: 97 nM; IC50: less than 2 nM | Mus musculus | |
(R)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]-1-methylethyl]-2-hydroxyacetamide | IC50: 3 nM; IC50: less than 2 nM | Mus musculus | |
(R)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]propyl]-2-hydroxyacetamide | IC50: 2 nM; IC50: less than 2 nM | Mus musculus | |
(S)-2-(2-[[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]methyl]pyrrolidin-1-yl)-2-oxoethanol | IC50: 2 nM; IC50: 327 nM | Mus musculus | |
(S)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]-1-methylethyl]-2-hydroxyacetamide | IC50: 19 nM; IC50: 2580 nM | Mus musculus | |
(S)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]propyl]-2-hydroxyacetamide | IC50: 191 nM; IC50: 22 nM | Mus musculus | |
N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]ethyl]-2-hydroxyacetamide | IC50: 35 nM, potent, orally active inhibitor when co-administered with the cytochrome P450 inhibitor 1-aminobenzotriazole; IC50: 4 nM, potent, orally active inhibitor when co-administered with the cytochrome P450 inhibitor 1-aminobenzotriazole | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
Egfr | - |
Mus musculus |
erbB2 receptor tyrosine kinase | - |
Mus musculus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000002 | - |
IC50: 2 nM | Mus musculus | (R)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]propyl]-2-hydroxyacetamide | |
0.000002 | - |
IC50: 2 nM | Mus musculus | (S)-2-(2-[[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]methyl]pyrrolidin-1-yl)-2-oxoethanol | |
0.000002 | - |
IC50: less than 2 nM | Mus musculus | (R)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]-1-methylethyl]-2-hydroxyacetamide | |
0.000002 | - |
IC50: less than 2 nM | Mus musculus | (R)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]propyl]-2-hydroxyacetamide | |
0.000002 | - |
IC50: less than 2 nM | Mus musculus | (R)-2-(2-[[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]methyl]pyrrolidin-1-yl)-2-oxoethanol | |
0.000003 | - |
IC50: 3 nM | Mus musculus | (R)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]-1-methylethyl]-2-hydroxyacetamide | |
0.000004 | - |
IC50: 4 nM, potent, orally active inhibitor when co-administered with the cytochrome P450 inhibitor 1-aminobenzotriazole | Mus musculus | N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]ethyl]-2-hydroxyacetamide | |
0.000019 | - |
IC50: 19 nM | Mus musculus | (S)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]-1-methylethyl]-2-hydroxyacetamide | |
0.000022 | - |
IC50: 22 nM | Mus musculus | (S)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]propyl]-2-hydroxyacetamide | |
0.000035 | - |
IC50: 35 nM, potent, orally active inhibitor when co-administered with the cytochrome P450 inhibitor 1-aminobenzotriazole | Mus musculus | N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]ethyl]-2-hydroxyacetamide | |
0.000097 | - |
IC50: 97 nM | Mus musculus | (R)-2-(2-[[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]methyl]pyrrolidin-1-yl)-2-oxoethanol | |
0.000191 | - |
IC50: 191 nM | Mus musculus | (S)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]propyl]-2-hydroxyacetamide | |
0.000327 | - |
IC50: 327 nM | Mus musculus | (S)-2-(2-[[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]methyl]pyrrolidin-1-yl)-2-oxoethanol | |
0.00258 | - |
IC50: 2580 nM | Mus musculus | (S)-N-[2-[(4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]quinazolin-5-yl)oxy]-1-methylethyl]-2-hydroxyacetamide |